Browse All

Current Filters

CLEAR FILTER x

TITLE

Real-world Use of Deutetrabenazine Reduces Tardive Dyskinesia Severity and Improves Quality of Life: Patient-reported Outcomes in the IMPACT-TD Study

Real-world Utility and Usability of the Multiple Sclerosis Disease Activity (MSDA) Blood Test: The Provider Experience

Real-world Utilization of a Novel Multi-analyte Blood-based Biomarker Panel, the Octave® Multiple Sclerosis Disease Activity (MSDA) Test in Clinical Practice Across the United States

Reanalysis of Global Neurodegeneration Proteomics Consortium Data Uncovers Pervasive Risk of False Positives and False Negatives in Biomarker Discovery from Large, Multi-center Proteomic Studies